5Wang Z,Liu Y, Liu J, et al. HSG/Mfn2 gene polymorphism andessential hypertension: a case-control association study in Chinese[J]. J Atheroscler Thromb,2011,18(1) : 24-31.
6American Diabetes Association. Standards of medical care in dia-betes-2013[J]. Diabetes Care,2013,36(Suppl 1):SI 1-66.
8Bakris GL, Sowers JR. ASH position paper: treatment of hyper-tension in patients with diabetes-an update [J]. J Clin Hypertens(Greenwich) ,2008,10(9) :707-713.
9Devereux RB,de Faire U, Fyhrquist F, et al. Blood pressure re-duction and antihypertensive medication use in the losartan inter-vention for endpoint reduction in hypertension (LIFE) study in pa-tients with hypertension and left ventricular hypertrophyf J]. CurrMed Res Opin,2007,23(2) :259-270.
10Tight blood pressure control and risk of macrovascular and micro-vascular complications in type 2 diabetes: UKPDS 38. UK pro-spective diabetes study group[J]. BMJ,1998,317(7160) :703-713.
